Paul B. Manning - 27 Jun 2024 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
10%+ Owner
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
27 Jun 2024
Transactions value $
$2,999,999
Form type
4
Filing time
01 Jul 2024, 08:00:07 UTC
Previous filing
27 Jun 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $2,999,999 +1,333,333 $2.25 1,333,333 27 Jun 2024 Direct
holding TSHA Common Stock 16,566,667 27 Jun 2024 See footnote F1
holding TSHA Common Stock 22,000 27 Jun 2024 See footnote F2
holding TSHA Common Stock 2,091,704 27 Jun 2024 See footnote F3
holding TSHA Common Stock 4,837,407 27 Jun 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Revocable Trust"). The Reporting Person is the trustee of the Revocable Trust and has sole voting and investment power with respect to the shares held by the Revocable Trust.
F2 The shares are held directly by BKB G2 Investments, LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2.
F3 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
F4 The shares are held directly by The PBM 2023 Grantor Retained Annuity Trust (the "Annuity Trust"). The Reporting Person is the trustee of the Annuity Trust and has sole voting and investment power with respect to the shares held by the Annuity Trust.